Use of systemic therapy in adults with moderate-to-severe atopic dermatitis: analysis from the CorEvitas Atopic Dermatitis Registry

被引：0

作者：

Simpson, Eric L. ^{[1
]}

Jones, Eric A. ^{[2
]}

Cronin, Angel ^{[2
]}

Dave, Swapna S. ^{[2
]}

McLean, Robert R. ^{[2
]}

Greenberg, Jeffrey ^{[2
]}

Strober, Bruce ^{[3
,4
]}

Bieber, Thomas ^{[5
]}

Gooderham, Melinda ^{[6
,7
]}

Paller, Amy S. ^{[8
,9
]}

Silverberg, Jonathan I. ^{[10
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR USA

[2] CorEvitas, Waltham, MA USA

[3] Yale Univ, New Haven, CT USA

[4] Cent Connecticut Dermatol Res, Cromwell, CT USA

[5] Univ Hosp Bonn, Bonn, Germany

[6] Skin Ctr Dermatol & Prob Med Res, Peterborough, ON, Canada

[7] Queens Univ, Kingston, ON, Canada

[8] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA

[9] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA

[10] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 187卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

183

引用

页码：E85 / E86

页数：2

共 50 条

[41] The economic impact of patients with moderate-to-severe atopic dermatitis eligible for systemic treatment
Ariens, L. F. M.
Van der Schaft, J.
Os-Medendorp, H.
De Bruin-Weller, M. S.
BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : E38 - E38
[42] Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review
Roekevisch, Evelien
Spuls, Phyllis Ira
Kuester, Denise
Limpens, Jacqueline
Schmitt, Jochen
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : 429 - 438
[43] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
Guttman-Yassky, E.
Okragly, A.
Sun, Z.
Mena, L.
Hahn, N.
Nickoloff, B.
Siu, K.
Gallo, G.
Wolf, E.
Eyerich, K.
Aparici, M.
Benschop, R.
EXPERIMENTAL DERMATOLOGY, 2024, 33 (03)
[44] Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis
Nettis, Eustachio
Patella, Vincenzo
Lombardo, Carla
Detoraki, Aikaterini
Macchia, Luigi
Di Leo, Elisabetta
Carbonara, Monica
Canonica, Giorgio W.
Bonzano, Laura
ALLERGY, 2020, 75 (10) : 2653 - 2661
[45] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children
Parker, Jennifer J.
Sugarman, Jeffrey L.
Silverberg, Nanette B.
Gonzalez, Mercedes Elena
Ramien, Michele L.
Teng, Joyce M. C.
Paller, Amy S.
PEDIATRIC DERMATOLOGY, 2021, 38 (06) : 1500 - 1505
[46] Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults
Lyakhovitsky, A.
Barzilai, A.
Heyman, R.
Baum, S.
Amichai, B.
Solomon, M.
Shpiro, D.
Trau, H.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (01) : 43 - 49
[47] A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults
Lynde, Charles W.
Bourcier, Marc
Gooderham, Melinda
Guenther, Lyn
Hong, Chih-ho
Papp, Kim A.
Poulin, Yves
Sussman, Gordon
Vender, Ronald
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2018, 22 (01) : 78 - 83
[48] Validation of the skin pain numerical rating scale of the Pruritus and Symptoms Assessment for Atopic Dermatitis for adults and adolescents with moderate-to-severe atopic dermatitis
Silverberg, Jonathan, I
Staender, Sonja
Kim, Brian S.
Bewley, Anthony
Misery, Laurent
Vestergaard, Christian
Gooderham, Melinda J.
Bushmakin, Andrew G.
Cappelleri, Joseph C.
Guler, Erman
Alderfer, Justine
Watkins, Melissa
Selfridge, Andrew
Myers, Daniela E.
BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II41 - II42
[49] Importance of concomitant topical therapy in moderate-to-severe atopic dermatitis treated with cyclosporine
Kim, Jeong Eun
Shin, Jae Min
Ko, Joo Yeon
Ro, Young Suck
DERMATOLOGIC THERAPY, 2016, 29 (02) : 120 - 125
[50] Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis
Li, Ling
Yu, Jiajun
Chen, Baoqing
Guo, Ying
Yang, Yufeng
FRONTIERS IN PHARMACOLOGY, 2023, 14

← 1 2 3 4 5 →